eMedicine Specialties > Plastic Surgery > Breast

Breast Augmentation, Submuscular: Treatment

Author: Jay M Pensler, MD, Aesthetic Plastic and Reconstructive Surgery, Private Practice; Clinical Associate Professor, Department of Surgery, Division of Plastic Surgery, Northwestern University Medical School
Contributor Information and Disclosures

Updated: Apr 7, 2006

Treatment

Surgical Therapy

Placement Route

Implants may be placed by a number of routes that typically vary with surgeon preference and experience. The individual's desired results may influence the site of implant placement.

Inframammary approach

An inframammary incision is the most common approach for placement of a breast implant. This approach, which entails a 3- to 4-cm incision, attempts to place the incision in or adjacent to the inframammary crease. The inframammary approach provides the most direct route and, in general, requires the least operative time for placement of the implant. Problems associated with inframammary incisions include a visible scar on the anterior surface of the breast. Additional problems center around the difficulty in placing the incision in the inframammary crease, which potentially is exacerbated with low-profile implants.

Periareolar approach

Implants placed by an incision within the pigmented areolar tissue, referred to as a periareolar incision, often result in the least conspicuous scar. However, dissection of the pocket required for implant placement is more difficult with a periareolar incision. Dissection must proceed through a portion of the breast tissue or in the subcutaneous plane. Problems with subcutaneous dissection include nodularity and inflammation. Incisions placed through the breast tissue or in the subcutaneous plane are associated with microcalcification and cyst formation. Medial placement of the periareolar implant incision within the areolar avoids the fourth intercostal nerve, which supplies sensation to the nipple and areola.

Transaxillary approach

Placing incisions in the axilla, referred to as a transaxillary approach, avoids placement of the scar on the breast. The transaxillary approach provides the worst exposure for placement of the implant, which is a disadvantage. This may be avoided using special instrumentation, including endoscopes and specific surgical instrumentation designed to aid the dissection. An increased incidence of paresthesia involving the nipple-areolar complex exists with this approach. Obtaining symmetric pockets is more difficult, and damage to the intercostal brachial nerve and subclavian venous thrombosis has been reported with this technique. Additionally, if infection results, removal of the implant may require conversion of the transaxillary incision to one of the other incisions listed above. Hypertrophic scar formation also can occur in the axilla, and the incision may be visible when the patient wears a sleeveless dress and elevates her arms.

Periumbilical approach

A periumbilical approach, involving placement through the umbilicus, can be used for augmentation of the female breast. Placement of the implant is restricted to a prepectoral plane, and this approach provides the worst control for dissection of the pockets. Superior dissection and symmetry of placement are difficult, even in the most experienced hands. Complications of hematoma or infection require conversion to one of the other incisions for implant removal. Additionally, placement of saline-filled implants through a periumbilical approach requires a special type of valvular mechanism, and long-term reliability of the valvular mechanism in these implants has not been fully clarified, at least to the author's satisfaction.

Implant Placement

Implants may be placed directly beneath the mammary gland or in a plane below the pectoralis major muscle. Advantages attributed to placement below the gland include ease of dissection, predictable sizing and contouring, and satisfactory results provided capsular contracture does not occur. Placement of larger implants in a subglandular position than in a submuscular position is also feasible.

(Above) A 24-year-old woman with an A-cup breast....

(Above) A 24-year-old woman with an A-cup breast. (Below) Postoperative result after subglandular placement with 460-cc implants. Note the lower position of the implant when placed subglandularly.

(Above) A 24-year-old woman with an A-cup breast....

(Above) A 24-year-old woman with an A-cup breast. (Below) Postoperative result after subglandular placement with 460-cc implants. Note the lower position of the implant when placed subglandularly.


Submuscular placement of implants was developed in response to problems associated with subglandular placement, specifically, capsular contracture and visibility of the edge of the implant.

(Above) Preoperative view of a 27-year-old patien...

(Above) Preoperative view of a 27-year-old patient desiring augmentation. (Below) Postoperative view after augmentation with a round implant. Notice the smooth contour in the upper pole. The end of the implant is not perceptible because of submuscular placement.

(Above) Preoperative view of a 27-year-old patien...

(Above) Preoperative view of a 27-year-old patient desiring augmentation. (Below) Postoperative view after augmentation with a round implant. Notice the smooth contour in the upper pole. The end of the implant is not perceptible because of submuscular placement.


Additional benefits attributed to submuscular placement include reduced sensory changes in the nipple, decreased rates of capsular contracture, and ease of interpretation of mammographic studies. The submuscular plane is avascular, and incidence of hematoma may be reduced by placement in the submuscular plane.

Disadvantages include potential limitations on the size of the implant, increased postoperative pain, and the possibility of lateral displacement of the implant. In addition, obtaining significant cleavage is more difficult with submuscular placement. If significant cleavage is desired, detach the inferior portion of the pectoralis musculature from its sternal attachments. This results in increased postoperative discomfort.

(Above) Preoperative view of 23-year-old patient ...

(Above) Preoperative view of 23-year-old patient with micromastia. (Below) Postoperative view after augmentation with detachment of the inferior half of the pectoralis musculature from the sternal attachments to provide cleavage. Note increased medial projection.

(Above) Preoperative view of 23-year-old patient ...

(Above) Preoperative view of 23-year-old patient with micromastia. (Below) Postoperative view after augmentation with detachment of the inferior half of the pectoralis musculature from the sternal attachments to provide cleavage. Note increased medial projection.


Complications

Hematoma

The frequency of hematomas is less than 2%. Associated symptoms of hematoma typically are unilateral pain, swelling, and occasionally fever. Hematomas may develop slowly without symptoms or rapidly with symptoms. Small hematomas may resolve without intervention, but large hematomas require drainage. Often, delaying drainage until liquefaction of the clot has occurred is preferable. However, if the hematoma is painful or large, drain it immediately.

Infection

Incidence of infection is approximately 2%. Infection typically becomes apparent 7-10 days postoperatively but may manifest at any point. Typical presenting symptoms of infection include swelling, discomfort, pain, drainage, and cellulitis overlying the breast. Typically, drain and irrigate the wound. Removal of the implant may not be necessary, particularly if a periareolar incision was used with initial surgery. Prescribe antibiotics immediately. If the implant is not removed, infection may result in severe capsular contracture. If the implant is removed following infection, it typically is replaced in 3-6 months. Staphylococcus epidermidis or Staphylococcus aureus commonly may cause infections. For more information, see eMedicine Infectious Diseases article Staphylococcal Infections.

Sensory changes

Changes in nipple-areolar sensation are common postoperatively in patients who have undergone breast augmentation. Most patients exhibit a temporary dysesthesia, which tends to resolve in a period of months. However, a small percentage of individuals may present with long-term sensory changes in one or both nipples following breast augmentation. An increased incidence of sensory changes is noted with transaxillary augmentation, since this approach directly crosses the fourth intercostal nerve, which supplies sensation to the nipple-areolar area.

Scars

Hypertrophic or keloid scar formation is uncommon following breast augmentation. The lowest incidence of hypertrophic scarring appears in periareolar incisions. The presence of a hypertrophic scar in inframammary or axillary incisions may require re-excision and closure of the incision.

Asymmetry

Asymmetry of the implant position may result from shifting of the implant, increased contraction of the capsule unilaterally, or ptosis of the implant, which is attributed to placement of steroids in the pocket and/or breast prosthesis.

Contour irregularity and implant extrusion

Contour irregularity and implant extrusion also are rare events that may be associated with the placement of implants. The most common cause of contour irregularity is a tight capsular contracture that may develop around the implant.2 A wide range of incidence of capsular contracture, from 0-74% of patients, has been noted following breast implantation. The incidence of capsular contracture appears to be approximately 30% of individuals who have undergone the procedure. Classification of the contracture is highly subjective. In 1980, Little and Baker developed a classification for the capsular contracture present in patients following breast augmentation, which remains the standard for evaluating this complication in patients. The grades of capsular contracture are divided into 4 types:

  1. Grade I: Capsular contracture of the augmented breast feels as soft as an unoperated breast.
  2. Grade II: Capsular contracture is minimal. The breast is less soft than an unoperated breast. The implant can be palpated but is not visible.
  3. Grade III: Capsular contracture is moderate. The breast is firmer. The implant can be palpated easily and may be distorted or visible.
  4. Grade IV: Capsular contracture is severe. The breast is hard, tender, and painful with significant distortion present. The capsule thickness is not directly proportional to palpable firmness, although some relationship may exist.

Subclinical infection may cause capsular contracture, with S epidermidis the most probable etiologic agent. Various techniques, including massage, which expands the size of the capsule, attempt to reduce the incidence of this complication. The role of antibiotics in the prevention of capsular contracture is unclear. Antibiotics may benefit if subclinical infection is a factor. However, in patients in whom this is not a problem, antibiotics provide no benefit to the individual. Capsule formation may require surgical capsulotomy, which involves circumferential and radial division of the capsule. In addition, the extent of the pocket is increased. Recurrence following capsulotomy approaches 30%. Complications of capsulotomy include bleeding, infection, and implant exposure.

In addition, contour irregularities may arise because of rippling of the implant. Individuals with thin skin are more susceptible to this problem. Silicone implants seem to be subject to less rippling, but they are currently available for this problem only with investigators in an approved protocol by the manufacturer.

Medicolegal pitfalls

Medicolegal pitfalls typically are concerned with informed consent. Discuss previously enumerated complications preoperatively. Recently, the Food and Drug Administration approved saline implants, but not for use in minors or via a periumbilical approach.

More on Breast Augmentation, Submuscular

Overview: Breast Augmentation, Submuscular
Treatment: Breast Augmentation, Submuscular
Follow-up: Breast Augmentation, Submuscular
Multimedia: Breast Augmentation, Submuscular
References

References

  1. Cronin T, Gerow F. Augmentation mammoplasty: A new "natural feel" prosthesis. In: Broadbent TR, ed. Transactions of the Third International Congress of Plastic Surgery. Amsterdam: Excerpta Medica Foundation; 1964.

  2. Asplund O. Capsular contracture in silicone gel and saline-filled breast implants after reconstruction. Plast Reconstr Surg. Feb 1984;73(2):270-5. [Medline].

  3. Ashley FL. A new type of breast prosthesis. Preliminary report. Plast Reconstr Surg. May 1970;45(5):421-4. [Medline].

  4. Baker JL Jr, Bartels RJ, Douglas WM. Closed compression technique for rupturing a contracted capsule around a breast implant. Plast Reconstr Surg. Aug 1976;58(2):137-41. [Medline].

  5. Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg. Jun 1979;63(6):812-6. [Medline].

  6. Courtiss EH, Webster RC, White MF. Selection of alternatives in augmentation mammaplasty. Plast Reconstr Surg. Nov 1974;54(5):552-7. [Medline].

  7. Cronin TD, Greenberg RL. Our experiences with the silastic gel breast prosthesis. Plast Reconstr Surg. Jul 1970;46(1):1-7. [Medline].

  8. De Cholnoky T. Augmentation mammaplasty. Survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg. Jun 1970;45(6):573-7. [Medline].

  9. Ellenberg AH, Braun H. A 3 1/2-year experience with double-lumen implants in breast surgery. Plast Reconstr Surg. Mar 1980;65(3):307-13. [Medline].

  10. Farina MA, Newby BG, Alani HM. Innervation of the nipple-areola complex. Plast Reconstr Surg. Oct 1980;66(4):497-501. [Medline].

  11. Goldwyn R. Plastic and Reconstructive Surgery of the Breast. Boston, Mass: Little Brown & Co; 1976.

  12. Irons GB, Arnold PG, Masson JK, Woods JE. Experience with 100 muscle flaps. Ann Plast Surg. Jan 1980;4(1):2-6. [Medline].

  13. Jones FR, Tauras AP. A periareolar incision for augmentation mammaplasty. Plast Reconstr Surg. Jun 1973;51(6):641-4. [Medline].

  14. Letterman G, Schurter M. History of augmentation mammoplasty. In: Owsley JQ, Peterson RA, eds. Symposium on Aesthetic Surgery of the Breast. St Louis:. CV Mosby Co;1978:243-49.

  15. Lilla JA, Vistnes LM. Long-term study of reactions to various silicone breast implants in rabbits. Plast Reconstr Surg. May 1976;57(5):637-49. [Medline].

  16. Mahler D, Ben-Yakar J, Hauben DJ. The retropectoral route for breast augmentation. Aesthetic Plast Surg. 1982;6(4):237-42. [Medline].

  17. McKinney P, Tresley G. Long-term comparison of patients with gel and saline mammary implants. Plast Reconstr Surg. Jul 1983;72(1):27-31. [Medline].

  18. Oneal RM, Argenta LC. Late side effects related to inflatable breast prostheses containing soluble steroids. Plast Reconstr Surg. Apr 1982;69(4):641-5. [Medline].

  19. Rees TD, Guy CL, Coburn RJ. The use of inflatable breast implants. Plast Reconstr Surg. Dec 1973;52(6):609-15. [Medline].

  20. Slade CL, Peterson HD. Disappearance of the polyurethane cover of the Ashley Natural Y prosthesis. Plast Reconstr Surg. Sep 1982;70(3):379-83. [Medline].

  21. Tebbetts JB. Transaxillary subpectoral augmentation mammaplasty: long-term follow-up and refinements. Plast Reconstr Surg. Nov 1984;74(5):636-49. [Medline].

  22. Tebbetts JB, Adams WP. Five critical decisions in breast augmentation using five measurements in 5 minutes: the high five decision support process. Plast Reconstr Surg. Dec 2005;116(7):2005-16. [Medline].

Further Reading

Keywords

breast augmentation, submuscular breast augmentation, breast implant, inframammary approach, periareolar approach, transaxillary approach, periumbilical approach, subglandular, implant rippling, micromastia, breast surgery, breast enlargement, silicone implants, gel implants, saline implants, submuscular

Contributor Information and Disclosures

Author

Jay M Pensler, MD, Aesthetic Plastic and Reconstructive Surgery, Private Practice; Clinical Associate Professor, Department of Surgery, Division of Plastic Surgery, Northwestern University Medical School
Jay M Pensler, MD is a member of the following medical societies: American Academy of Pediatrics, American Burn Association, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Medical Association, American Society for Aesthetic Plastic Surgery, American Society for Laser Medicine and Surgery, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, Chicago Medical Society, Illinois State Medical Society, International College of Surgeons, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Christian Paletta, MD, FACS, Professor, Division Chief and Program Director, Department of Plastic and Reconstructive Surgery, St Louis University School of Medicine
Christian Paletta, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Association of Plastic Surgeons, American Burn Association, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Medical Association, and Missouri State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Saleh M Shenaq, MD†, Former Director and Founder, The International Brachial Plexus Institute; Former Chief, Section of Plastic Surgery, Methodist Hospital, Houston
Saleh M Shenaq, MD† is a member of the following medical societies: American Academy of Anti-Aging Medicine, American Academy of Pediatrics, American Association for Hand Surgery, American Association for the Advancement of Science, American Association of Plastic Surgeons, American Burn Association, American College of Physician Executives, American College of Surgeons, American Congress of Rehabilitation Medicine, American Medical Association, American Society for Aesthetic Plastic Surgery, American Society for Reconstructive Microsurgery, American Society for Surgery of the Hand, American Society of Gene Therapy, American Society of Law Medicine and Ethics, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, American Trauma Society, Association for Academic Surgery, International College of Surgeons, Lipoplasty Society of North America, Plastic Surgery Research Council, Society for Neuroscience, Society of Surgical Oncology, Southern Medical Association, Texas Medical Association, and Texas Society of Plastic Surgeons
Disclosure: Nothing to disclose.

CME Editor

Nicolas (Nick) G Slenkovich, MD, Director, Colorado Plastic Surgery Center
Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, and Colorado Medical Society
Disclosure: Nothing to disclose.

Chief Editor

Lars M Vistnes, MD, FRCSC, FACS, Professor of Surgery, Emeritus, Stanford University Medical Center
Lars M Vistnes, MD, FRCSC, FACS is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.